Savita Rangarajan

Employment

• University of Southampton

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (98)

• Nonneutralizing antibodies in haemophilia A patients: to be ignored or not to be!
  Haemophilia 2026 0 citations DOI: 10.1111/hae.70322
  +Save
• Natural history and quality of life in patients with Glanzmann thrombasthenia and Bernard Soulier syndrome: an observational study from India
  Indian Journal of Medical Research 2025
  +Save
• A survey to assess the knowledge and perceptions about gene therapy in Indian haemophilia patients
  Indian Journal of Hematology and Blood Transfusion 2025 0 citations DOI: 10.1007/s12288-024-01945-1
  +Save
• Quality of life and treatment satisfaction in people with haemophilia on fitusiran prophylaxis: evidence from a subset of ATLAS-OLE trial participants mainly from India
  Haemophilia 2025 0 citations DOI: 10.1111/hae.70134
  +Save
• Bleeding disorders of unknown cause: a conglomeration of disorders with heterogeneous etiology
  Thrombosis Research 2025 0 citations DOI: 10.1016/j.thromres.2025.109496
  +Save
• Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study
  Blood 2025 42 citations DOI: 10.1182/blood.2024027008
  +Save
• Mortality in haemophilia patients in India: a national cohort study
  Haemophilia 2024 0 citations DOI: 10.1111/hae.15143
  +Save
• Long-term clinical outcomes of prophylaxis with an rFVIIIFc or rFIXFc in adults aged ≥50 years with hemophilia A or B
  Blood Advances 2024 1 citation DOI: 10.1182/bloodadvances.2023012462
  +Save
• Long-term clinical outcomes of prophylaxis with an rFVIIIFc or rFIXFc in adults aged ≥50 years with hemophilia A or B
  Blood Advances 2024
  +Save
• Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia A
  Haemophilia 2024 37 citations DOI: 10.1111/hae.15071
  +Save